Showing 991-1000 of 19239 results for "".
Improving Sleep and Mental Health in Patients with CKD-aP
https://reachmd.com/programs/cme/improving-sleep-and-mental-health-in-patients-with-ckd-ap/36301/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
https://reachmd.com/programs/cme/understanding-igan-fsgs-pathophysiology-and-emerging-therapies/14974/Hear experts discuss how emerging therapies for IgAN and FSGS may achieve proteinuria remission and shape clinical treatment decisions for patients.In Your Waiting Room: The Virtual IBS-C Patient Clinical Experience
https://reachmd.com/programs/cme/in-your-waiting-room-the-virtual-ibs-c-patient-clinical-experience/14955/What else can you do for your patients with IBS-C whose current therapies aren’t enough? Join our experts to explore the stories of 3 patients.The FDA Expands Indication for Baloxavir Marboxil to Include Post-Exposure Influenza Prevention
https://reachmd.com/programs/the-drug-report/the-fda-expands-indication-for-baloxavir-marboxil-to-include-post-exposure-influenza-prevention/12043/Previously used for acute uncomplicated influenza, baloxavir marboxil has been approved by the FDA for post-exposure influenza prevention.The Impact of ESHRE 2017 on Japanese Fertility Practice
https://reachmd.com/programs/global-womens-health-academy/impact-eshre-2017-japanese-fertility-practice/9787/This activity includes summaries and impacts of ESHRE 2017 from thought leaders, pertaining to practicing Japanese fertility specialists.Modern Obstructive HCM Care: From Unmet Needs to Individualized Myosin Inhibitor Therapy
https://reachmd.com/programs/cme/modern-obstructive-hcm-care-from-unmet-needs-to-individualized-myosin-inhibitor-therapy/54306/Explore how cardiac myosin inhibitors are reshaping obstructive HCM management, from unmet needs to individualized, evidence-based treatment.Frontline Insights: Emerging Therapeutic Strategies in HNSCC
https://reachmd.com/programs/cme/Frontline-Insights-Emerging-Therapeutic-Strategies-in-HNSCC/49223/Review emerging therapeutic strategies in HNSCC across disease states and learn to compare safety profile to improve AE recognition, prevention, and management.Decoding Itch in CKD: From CKD-aP Suspicion to Solution
https://reachmd.com/programs/cme/decoding-itch-in-ckd-from-ckd-ap-suspicion-to-solution/26640/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.Clinical Implications of Emerging Data on B7-H3–directed ADCs in the Future of ES-SCLC
https://reachmd.com/programs/cme/clinical-implications-of-emerging-data-on-b7-h3directed-adcs-in-the-future-of-es-sclc/39979/Explore recent clinical data on B7-H3 ADCs in ES-SCLC, with expert insights on biological rationale, efficacy outcomes, safety profiles, and patient selection.Long-term improvements in daily steps with gamification and financial incentives in patients at risk for CV events
https://reachmd.com/programs/acc-action-center/long-term-improvements-in-daily-steps-with-gamification-and-financial-incentives-in-patients-at-risk-for-cv-events/24347/ACC.24 - Alexander Fanaroff shares the results of the BE ACTIVE trial, which investigated the long-term efficacy of gamification, financial incentives, or a combination of both approaches for increasing physical activity in patients at risk for cardiovascular events.